Hi Jim,
  The 2 data marts per site comment was directly from Leslie and Jeff.  I
have heard them discuss it before and  I assumed they discussed it with
all the CDRNs.  I agree that there is nothing explicit in the CDM specs
referencing the 2 data mart deployment and that is troubling.

You may want to ask them directly about the 2 data mart approach.  Perhaps
they have not communicated this suggestion as thoroughly as they thought.
I don’t like the 2 data mart approach since PopMedNet does not permit
queries across the data marts.

Chuck

On 5/21/15, 4:34 PM, "Campbell, James R" <[email protected]> wrote:

>Charles
>This comment about two datamarts per site is something brand new to me.
>There is certainly nothing explicit in CDM specs that imply such a
>requirement.  
>From our i2b2 native reference datasets, we have SQL queries that prepare
>the data in CDM table format although the jump from CDM V2 to V3 is going
>to be troublesome, as I indicated to Russ
>Jim
>
>James R. Campbell MD
>[email protected]
>Office 402-559-7505
>Secretary 402-559-7299
>Fax 402-559-8396
>Pager 402-888-1230
>
>-----Original Message-----
>From: Borromeo, Charles [mailto:[email protected]]
>Sent: Thursday, May 21, 2015 9:00 AM
>To: Russ Waitman; Campbell, James R; [email protected]; McClay,
>James C
>Cc: Mandl, Kenneth ([email protected]); Shawn N. Murphy
>([email protected]); Rachel Hess ([email protected])
>Subject: Re: PCORI CDM V3 vote
>
>Hi Russ,
>  We met with DSSNI on Monday.  The PaTH CDRN shares your concerns about
>the non-EAV structure of the data model.  Dr. Chris Chute (recently joined
>JHU) also thinks the CDM is very brittle.  However, PaTH never dedicated
>time to developing a viable alternative to the CDM.  It seemed like too
>big of a change to discuss given the CDM 3.0 approval date of May 2015.
>
>I did discuss a short-term flaw with Jeff, Leslie, Laura, and Rich Platt.
>In PaTH, I am developing some Python scripts to convert our i2b2 data
>into the CDM.  According to DSSNI, the CDRNs should deploy 2 DataMarts:
>one with EMR data and one with Claims data.  Deploying two DataMarts
>allows the CDRNs to avoid the issue of combining Claims Encounters with
>EMR Encounters.  Leslie said some CDRNs are required to keep the Claims
>data separate from the EMR data thus necessitating 2 DataMarts.  During
>the development process I found a flaw with the 2 DataMart approach.
>Basically, the Claims only DataMart would be missing data in several
>tables (see attached image) including: VITAL, CONDITION, PRO_CM,
>LAB_RESULT_CM, and PRESCRIBING.  The data for these tables comes from the
>EMR, not claims.  Therefore, the Claims Only DataMart would only be able
>to answer a subset of research questions.  During the discussion, it
>appeared that Jeff Brown did not have a technical solution allowing him
>to query across the 2 DataMarts in a single query.  Therefore, storing
>the data in one DataMart would answer more research questions.
>
>I suggested that DSSNI add some columns to the tables allowing the ETL
>process to describe the data provenance.  The columns would include
>information about the type of encounter (inpatient vs outpatient) and
>datasource (claims vs EMR).  Some of the tables (like PROCEDURES) already
>have these columns (ENC_TYPE and PX_TYPE).  DSSNI would need to check the
>other tables to ensure this information.  This approach effectively
>demotes the importance of the encounter and eliminates the need to
>combine encounters.  There may be some other alternatives.
>
>Jeff said he would give this some consideration so we will see what
>happens.
>
>Chuck Borromeo   
>
>From:  Russ Waitman <[email protected]>
>Date:  Thursday, May 21, 2015 at 9:20 AM
>To:  "'Campbell, James R'" <[email protected]>,
>"[email protected]" <[email protected]>, "'McClay, James
>C ([email protected])'" <[email protected]>
>Cc:  Charles Borromeo <[email protected]>, "Mandl, Kenneth
>([email protected])"
><[email protected]>, "Shawn N. Murphy
>([email protected])" <[email protected]>, Rachel Hess
><[email protected]>
>Subject:  RE: PCORI CDM V3 vote
>
>
>Dear Jim and GPC Dev,
>Thanks for the good discussion Tuesday regarding the CDM 3 vote:
>
>https://docs.google.com/document/d/1ih4XGJVrTjIH7xOHAnQOqfqKvLl9ZxovS5PXgF
>O
>T7qo/edit
><https://docs.google.com/document/d/1ih4XGJVrTjIH7xOHAnQOqfqKvLl9ZxovS5PXg
>F
>OT7qo/edit>
> 
>Did we as the GPC or any other CDRNs ever propose alternatives or
>improved modifications to the CDM draft?
> 
>If not, was it because
>
>-         
>No opportunity
>-         
>there was a sense it was futile
>-         
>No interest
>
> 
>Do we have written recommendations to improve CDM3 or specifically
>identify the flaws or most difficult to maintain sections?
>
> 
>At a high level I view adding prescribing/ordered medications as good
>
> 
>I am still concerned this non-EAV model or each domain is very expensive
>to augment and maintain
>
> 
>It would be preferable to share extensible enhancements with the group as
>an alternative,
> 
>Russ
> 
> 
> 
>From: Campbell, James R [mailto:[email protected]]
>
>Sent: Monday, May 18, 2015 7:10 AM
>To: Russ Waitman
>Subject: RE: PCORI CDM V3 vote
>
>
> 
>On Saturday PCORI preemptively cancelled the DSSNI call scheduled for
>today.  There has been no organized discussion of CDM for a month now.
>They have moved the decision making
> to the PIs, apparently to limit debate and need for their response.  It
>seems they have been missing every deadline they set for themselves and I
>am not sure what to expect.  Are you saying they have not been discussing
>this within the PI steering group either?
>Jim
>________________________________________
>
>From: Russ Waitman [[email protected]]
>Sent: Monday, May 18, 2015 6:25 AM
>To: Campbell, James R
>Cc: Dan Connolly; McClay, James C
>Subject: Re: PCORI CDM V3 vote
>
>That secure transmission is the fault of the KUMC email system.  No idea
>why it did that.
>
> 
>
>I think we are all somewhat non-enthusiastic of the direction of the CDM.
>
> 
>
>Do you have suggestions that would improve the next iteration?  Any
>chance to bring those forward to Disney?
>
> 
>
>Russ
>On May 17, 2015, at 10:23 AM, Campbell, James R <[email protected]> wrote:
>
> 
>Russ,
>
>Thanks for sharing the CDM V3 document with me.  Why the secure
>transmission?  I thought  this was public knowledge?
>
> 
>
>Have they been discussing these changes in the CDM in the PI forum?
>Looking through the copy that you sent me I count over 35 data
>attributes ADDED since our input was tendered on V3.  Many of those
>additions do nothing to improve data quality (like all the temporary
>primary identifier fields we will have to generateŠ..we need to be sure
>they  are serious that we do not have to maintain IDs across refresh
>cycles) and will be a lot of work for GPC data managers.  I can
>understand hat perhaps they will be useful for the central data warehouse
>managers and presume that is where the requirements originated.
>
> 
>
>I assume that many networks are refusing to release non-obfuscated dates
>without full IRB and so I appreciate the rationale for the proliferation
>of HARVEST.Attributes but that  table will have to be regenerated for
>each trial report assuming that we will have a mixture of IRB approved
>and non-approved trials.
>
> 
>
>They are giving lip service to compliance with meaningful use
>standardization but are adding duplicate data identification requirements
>(PRO_CM.PRO_ITEM; LAB_RESULT.LAB_NAME are
> examples) that create overhead for our data managers and require mapping
>tables in addition to what our sites are doing for ONC compliance.
>
> 
>
>I was suprized by the appearance of the table 2.5 ³Implementation
>Expectations²  table of page 6.  Are  a lot of CDRNs not able to produce
>LAB, CONDITION, DEATH and PRESCRIBING datasets?  Will these be the
>factors that separate the men from the boys in trial participation?  I
>don¹t see how they can do the ADAPTABLE  trial from EHR data harvest
>without some of these data sets.
>
> 
>
>In short, this V3 document creates a lot of new requirements for our data
>managers, many with apparently arbitrary specs.  If we can  take table
>2.5 literally, GPC should be able to meet CDM compliance in the next few
>months but I ask if the OPTIONAL tables will not be the mark of the truly
>successful CDRN and therefore required for our long term viability.
>
> 
>
>Please provide your prospectives on this.  What is the discussion among
>PIs?  Is the snowball already hallway down the hill?
>
>Jim
>
> 
>
>NEW or REVISED ELEMENTS IN CDM V3
>
>DIAGNOSIS.DIAGNOSISID (Unique over time for all queries to site?? They
>say no and so I ask WHY?)
>
>PROCEDURE.PROCEDURESID
>
>VITAL.SMOKING
>
>VITAL.TOBACCO (CHANGED FROM V2; IT APPEARS THAT THEY HAVE CREATED
>DUPLICATE ENTRIES FOR SMOKING BEHAVIOR AND HAVE CHANGED V2 DEFINITIONS ON
>TOBACCO TYPE.  THIS  FLIES IN THE FACE OF WHAT WE ARE BEING REQUIRED TO
>REPORT FOR MEANINGFUL USE )
>
>VITAL.TOBACCO_TYPE
>
>DISPENSING.DISPENSINGID
>
>DISPENSING.PRESCRIBINGID (QUESTIONABLE ADDITION!  THOSE OF OUR SITES THAT
>CAN REPORT THIS WILL BE ACCEPTING SURESCRIPTS DATA THAT THEY  HAVE NOT
>ORIGINATED)
>
>DISPENSING.NDC (SHOULD SPECIFICALLY DRAW FROM NLM RXNAV PUBLICATION)
>
>[LAB_RESULT.LAB_NAME CREATES BURDEN FOR MAPPING ALL TEST NAMES IN
>ADDITION TO LOINC SOTH NAME WHICH SHOULD BE QUITE ADEQUATE FOR RESEARCH
>PURPOSES]
>
>LAB_RESULT.NORM_MODIFIER_LO
>
>LAB_RESULT.NORM_MODIFIER_HI
>
>CONDITION.CONDITIONID
>
>PRO_CM.PRO_CMID
>
>PRO_CM.PRO_ITEM (REDUNDANT WITH LOINC CODE ?WHY?)
>
>PRESCRIBING.ORDER_TIME
>
>PRESCRIBING _FREQUENCY
>
>PRESCRIBING.RX_BASIS (NEW; THIS IS INCONSISTENT WITH GUIDANCE ON NATURE
>OF THE DISPENSING RECORD AND MAKES NO SENSE!)
>
>PCORNET_TRIAL.PARTICIPANTID
>
>PCORNET_TRIAL.TRIALSITEID
>
>HARVEST.BIRTH_DATE_MGMT
>
>HARVEST.ENR_START_DATE_MGMT
>
>HARVEST.ENR_END_DATE_MGMT
>
>HARVEST.ADMIT_DATE_MGMT
>
>HARVEST.DISCHARGE_DATE_MGMT
>
>HARVEST.PX_DATE_MGMT
>
>HARVEST.RX_ORDER_DATE_MGMT
>
>HARVEST.RX_START_DATE_MGMT
>
>HARVEST.RX_END_DATE_MGMT
>
>HARVEST .RESULT_DATE
>
>HARVEST .MEASURE_DATE
>
>HARVEST.ONSET_DATE_MGMT
>
>HARVEST.REPORT_DATE_MGMT
>
>HARVEST.RESOLVE_DATE_MGMT
>
>HARVEST.PRO_DATE_MGMT
>
>HARVEST.REFRESH_DEMOGRAPHIC_DATE
>
>HARVEST.REFRESH_PRESCRIBING_DATE
>
>HARVEST.REFRESHPCORNET_TRIAL_DATE
>
>HARVEST.REFRESH_DEATH_DATE
>
>HARVEST.REFRESH_DEATH_CAUSE_DATE
>
>
>
>The information in this e-mail may be privileged and confidential,
>intended only for the use of the addressee(s) above. Any unauthorized use
>or disclosure of this information is prohibited. If you have received
>this e-mail by mistake, please delete it and immediately  contact the
>sender. <v3_VOTE.docx>
>
>
> 
>Russ Waitman, PhD
>
>Director of Medical Informatics
>
>Assistant Vice Chancellor for Enterprise Analytics
>
>Associate Professor, Department of Internal Medicine
>
>University of Kansas Medical Center, Kansas City, Kansas
>
>913-945-7087 (office)
>
>[email protected]
>
>http://www.kumc.edu/ea-mi/
>
>http://informatics.kumc.edu <http://informatics.kumc.edu/>
>
>http://informatics.gpcnetwork.org ­ a PCORNet collaborative
>
>
> 
>
> 
>
> 
>
>

_______________________________________________
Gpc-dev mailing list
[email protected]
http://listserv.kumc.edu/mailman/listinfo/gpc-dev

Reply via email to